Epigenetic Immune Cell Counting to Analyze Potential Biomarkers in Preterm Infants: A Proof of Principle in Necrotizing Enterocolitis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24032372 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Michiel H D Schoenaker und 7 weiteren Autor:innen. Beteiligte Einrichtung: Willem Alexander Children's Hospital, Laboratory for Pediatric Immunology, Department of Pediatrics, Leiden University Medical Center, 2300 RC Leiden…. Hauptthemen laut MEDLINE: Enterocolitis, Necrotizing, Infant, Newborn, Diseases, Fetal Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Janivo Stichting, Janivo Foundation, Epimune GmbH.
Themen: Neonatologie
Abstract (Originalsprache)
Epigenetic immune cell counting is a DNA (de)methylation-based technique which can be used to quantify lymphocyte subsets on dried blood spots (DBS). The foregoing techniques allow for a retrospective investigation of immune cell profiles in newborns. In this study, we used this technique for determining lymphocyte subcounts as a potential biomarker for necrotizing enterocolitis (NEC). We investigated whether this technique can be implemented in the field of neonatology, by testing whether regulatory T cell (Treg) levels are pre-existently low in preterms with NEC. Newborn screening (NBS) cards from 32 preterms with NEC and 32 age- and weight-matched preterm controls, and 60 healthy term newborns, were analyzed. Relative and absolute cell counts were determined for CD3+, CD4+, CD8+, Th17, and Treg T cells. For both relative and absolute cell counts of CD3+, CD4+, CD8+, and Th17 T cells, significant differences were found between healthy term controls and both preterm groups, but not between preterm groups. For Tregs, no significant differences were found in either relative or absolute counts between any of the newborn groups. This study demonstrates the principle of epigenetic immune cell counting to analyze lymphocyte subsets in preterm neonates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Willem Alexander Children's Hospital, Laboratory for Pediatric Immunology, Department of Pediatrics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
- Willem Alexander Children's Hospital, Division of Neonatology, Department of Pediatrics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
- Department of Pediatrics, Willem Alexander Children's Hospital, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
- Department of Research and Development, Epimune GmbH, 12489 Berlin, Germany.
ORCID-Profile: Vincent Bekker, Jeannette Werner, Janika J Schulze, Mirjam van der Burg, Maartje Blom
Förderung
- Janivo Stichting
- Janivo Foundation
- Epimune GmbH
Zitieren
APA
Schoenaker, M. H. D., Zuiderwijk, M. O., Bekker, V., Bredius, R. G. M., Werner, J., Schulze, J. J., van der Burg, M., & Blom, M. (2023). Epigenetic Immune Cell Counting to Analyze Potential Biomarkers in Preterm Infants: A Proof of Principle in Necrotizing Enterocolitis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032372
Vancouver
Schoenaker MHD, Zuiderwijk MO, Bekker V, Bredius RGM, Werner J, Schulze JJ, et al. Epigenetic Immune Cell Counting to Analyze Potential Biomarkers in Preterm Infants: A Proof of Principle in Necrotizing Enterocolitis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032372
BibTeX
@article{Schoenaker2023,
author = {Schoenaker, Michiel H D and Zuiderwijk, Mara O and Bekker, Vincent and Bredius, Robbert G M and Werner, Jeannette and Schulze, Janika J and van der Burg, Mirjam and Blom, Maartje},
title = {Epigenetic Immune Cell Counting to Analyze Potential Biomarkers in Preterm Infants: A Proof of Principle in Necrotizing Enterocolitis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24032372}
}
EUVIMED